Published in Retina on September 01, 2013
Ozurdex for the Treatment of a Patient with Birdshot Chorioretinopathy. Case Rep Ophthalmol (2015) 0.78
Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment. Orphanet J Rare Dis (2016) 0.78
Birdshot retinochoroidopathy. J Ophthalmic Vis Res (2015) 0.76
Birdshot uveitis: current and emerging treatment options. Clin Ophthalmol (2013) 0.75
A note on robust variance estimation for cluster-correlated data. Biometrics (2000) 15.61
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol (2005) 13.50
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology (2005) 4.01
Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol (1996) 3.67
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol (2008) 3.14
Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol (1996) 3.04
Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol (1982) 2.61
Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2004) 2.46
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology (2006) 2.35
Birdshot retinochoroidopathy. Am J Ophthalmol (1980) 2.29
Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol (2007) 2.18
Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol (2006) 2.06
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology (2011) 2.00
Birdshot chorioretinopathy: long-term manifestations and visual prognosis. Ophthalmology (2004) 1.75
The role of steroids in outflow resistance. Exp Eye Res (2008) 1.71
Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology (2000) 1.70
Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma. Am J Ophthalmol (2010) 1.66
Birdshot retinochoroidopathy. Br J Ophthalmol (1999) 1.48
Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology (2010) 1.34
Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol (2005) 1.31
Intraocular pressure response to topical corticosteroids. Fed Proc (1966) 1.30
Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest Ophthalmol Vis Sci (2000) 1.28
Glaucoma associated with uveitis. Surv Ophthalmol (1997) 1.24
Outcome of intravitreal triamcinolone in uveitis. Ophthalmology (2005) 1.23
A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol (2002) 1.22
Glaucoma in patients with uveitis. Br J Ophthalmol (1990) 1.22
Birdshot retinochoroiditis: long term follow-up of a chronically progressive disease. Am J Ophthalmol (2002) 1.20
Incidence of glaucoma in patients with uveitis. J Glaucoma (2004) 1.14
Loss of visual field among patients with birdshot chorioretinopathy. Am J Ophthalmol (2007) 1.08
HLA-A29.2 subtype associated with birdshot retinochoroidopathy. Am J Ophthalmol (1992) 1.07
HLA typing in birdshot chorioretinopathy. Am J Ophthalmol (1988) 1.03
Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis. Ophthalmology (2011) 1.02
Management of sympathetic ophthalmia with the fluocinolone acetonide implant. Ophthalmology (2009) 0.93
Pathophysiology of glaucoma in uveitis. Trans Ophthalmol Soc U K (1981) 0.90
Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis. Ophthalmology (1996) 0.88
Outcomes of birdshot chorioretinopathy treated with an intravitreal sustained-release fluocinolone acetonide-containing device. Am J Ophthalmol (2011) 0.86
Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant. Ocul Immunol Inflamm (2008) 0.82
Control of visual symptoms in two men with birdshot retinochoroidopathy using low-dose oral corticosteroid therapy. Am J Ophthalmol (1999) 0.82
Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis. Am J Ophthalmol (2008) 0.80
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain (2011) 3.48
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol (2012) 2.79
Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology (2004) 2.63
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23
Evaluation of patients with scleritis for systemic disease. Ophthalmology (2004) 2.22
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Development and validation of an improved neurological hemifield test to identify chiasmal and postchiasmal lesions by automated perimetry. Invest Ophthalmol Vis Sci (2014) 2.05
Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol (2009) 2.02
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology (2011) 2.00
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study. J Ophthalmic Inflamm Infect (2013) 1.85
Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75
The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med (2005) 1.75
Evaluation of patients with dry eye for presence of underlying Sjögren syndrome. Cornea (2009) 1.69
Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol (2007) 1.66
Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61
Methotrexate for ocular inflammatory diseases. Ophthalmology (2009) 1.58
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. JAMA Ophthalmol (2013) 1.55
Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology (2010) 1.54
Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology (2013) 1.51
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology (2008) 1.46
Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology (2005) 1.46
Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity. Ophthalmology (2006) 1.45
Azathioprine for ocular inflammatory diseases. Am J Ophthalmol (2009) 1.44
Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol (2006) 1.43
Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol (2009) 1.41
Replication of the TCF4 intronic variant in late-onset Fuchs corneal dystrophy and evidence of independence from the FCD2 locus. Invest Ophthalmol Vis Sci (2011) 1.39
Correspondence. Retina (2016) 1.38
Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36
Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation. Retina (2007) 1.34
Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol (2009) 1.33
Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol (2005) 1.31
Progression of macular ischemia following intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging (2009) 1.25
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol (2008) 1.23
Prevalence and severity of fuchs corneal dystrophy in Tangier Island. Am J Ophthalmol (2012) 1.19
Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol (2003) 1.18
Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr (2015) 1.17
Cyclophosphamide for ocular inflammatory diseases. Ophthalmology (2009) 1.14
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. Ophthalmology (2004) 1.13
Monitoring ocular drug therapy by analysis of aqueous samples. Ophthalmology (2009) 1.12
Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography. Am J Ophthalmol (2011) 1.12
Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol (2005) 1.11
Acute posterior multifocal placoid pigment epitheliopathy associated with a systemic necrotizing vasculitis. Retina (2003) 1.10
Age-severity relationships in families linked to FCD2 with retroillumination photography. Invest Ophthalmol Vis Sci (2010) 1.09
Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis (2003) 1.09
Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol (2009) 1.08
Wide-field retinal imaging in the management of noninfectious posterior uveitis. Am J Ophthalmol (2012) 1.08
Loss of visual field among patients with birdshot chorioretinopathy. Am J Ophthalmol (2007) 1.08
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci (2012) 1.07
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology (2004) 1.07
Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis (2014) 1.06
Minimally invasive spigelian hernia repair. JSLS (2009) 1.04
Use of colour Doppler imaging in ocular blood flow research. Acta Ophthalmol (2011) 1.04
Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am (2007) 1.04
Risk of hypotony in noninfectious uveitis. Ophthalmology (2012) 1.03
Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol (2008) 1.03
Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol (2013) 1.02
Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology (2013) 1.02
Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant. Am J Ophthalmol (2012) 1.01
Auditory force feedback substitution improves surgical precision during simulated ophthalmic surgery. Invest Ophthalmol Vis Sci (2013) 1.01
Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia. Arch Ophthalmol (2007) 1.01
Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. J Clin Invest (2014) 0.99
Hypopyon in patients with uveitis. Ophthalmology (2009) 0.99
A method of reporting macular edema after cataract surgery using optical coherence tomography. Retina (2008) 0.99
Safety of intravitreal ketorolac and diclofenac: an electroretinographic and histopathologic study. Retina (2008) 0.98
Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol (2004) 0.97
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology (2012) 0.97
Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis. J Ophthalmic Inflamm Infect (2013) 0.95
Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor (2009) 0.95
Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol (2012) 0.93
Response of pediatric uveitis to tumor necrosis factor-α inhibitors. J Rheumatol (2013) 0.90
Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Arch Dermatol (2003) 0.88
Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett (2008) 0.88
Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis. Am J Ophthalmol (2005) 0.88
Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer. Ocul Immunol Inflamm (2010) 0.88
Optic neuropathy complicating multifocal choroiditis and panuveitis. Am J Ophthalmol (2006) 0.87
Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis. Am J Ophthalmol (2011) 0.87
Uveitis in human immunodeficiency virus-infected persons with CD4+ T-lymphocyte count over 200 cells/mL. Clin Experiment Ophthalmol (2013) 0.87
The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology (2003) 0.86
CTG18.1 Expansion in TCF4 Increases Likelihood of Transplantation in Fuchs Corneal Dystrophy. Cornea (2017) 0.85
Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression. Am J Ophthalmol (2004) 0.85
Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr (2016) 0.85
Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with disease-associated factors and mortality. Am J Ophthalmol (2011) 0.84
Impact of Trichiasis surgery on physical functioning in Ethiopian patients: STAR trial. Am J Ophthalmol (2011) 0.84
Transient band keratopathy associated with ocular inflammation and systemic hypercalcemia. Clin Ophthalmol (2008) 0.84
Long-term preservation of vision in progressive outer retinal necrosis treated with combination antiviral drugs and highly active antiretroviral therapy. Ocul Immunol Inflamm (2007) 0.84